Mark Leonard Singleton - 24 Mar 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & CFO
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol
BVS
Transactions as of
24 Mar 2023
Net transactions value
-$7,676
Form type
4
Filing time
27 Mar 2023, 19:27:14 UTC
Previous filing
23 Mar 2023
Next filing
12 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Sale $7,676 -6,044 -32% $1.27 12,581 24 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2023 pursuant to a standing Rule 10b5-1 instruction provision in the award agreement, dated March 21, 2022.